Given the increasing incidences of COVID-19 infection in Europe and the threat of Omicron variant transmission, it might be a good idea to invest in work-from home stocks DoorDash. Roku Teladoc Health (NYSE 🙂 and (NASDAQ :). Wall Street analysts believe these names will gain significant in the coming months. Keep reading. Europe has seen a rapid rise in COVID-19-related infections. Therefore, Austria and the Netherlands, among others, have implemented partial lockdowns that will prevent spread. Investors were watching the European situation closely when the World Health Organization last week announced the emergence of a heavily mutated strain of the COVID-19 virus named ‘Omicron.’

The Omicron variant was spreading worldwide as of Nov 28, 2021. There had been thirteen cases in Australia, two in Denmark, and one each in Australia. U.K. Health Minister Sajid Javid said that the variant “may be more transmissible” than the Delta strain and that “the vaccines that we currently have may be less effective.” Against this backdrop, the work from home trend could be sustained in the near term. A Small Business Trends report shows that 32% of global employees will work remotely by 2021. This is up from 17% in 2019.

So, with countries once again imposing social distancing norms and travel restrictions to keep the new variant at bay, it could be wise to add work-from-home stocks DoorDash, Inc. (DASH), Roku, Inc. (ROKU), and Teladoc Health, Inc. (TDOC) to one’s portfolio now. Wall Street analysts anticipate these stocks will rise in value in the short term.

Continue reading on StockNews